Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease
- PMID: 24117880
- PMCID: PMC3979522
- DOI: 10.1111/jre.12132
Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease
Abstract
Background and objective: Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and have anti-inflammatory effects independent of cholesterol lowering. Recent clinical studies have indicated that statin intake has a beneficial effect on periodontal disease. However, the underlying mechanisms have not been well understood. In the current study, we employed a rat model with lipopolysaccharide (LPS)-induced periodontal disease and determined the effect of simvastatin, a commonly prescribed statin, on osteoclastogenesis, gingival inflammation and alveolar bone loss.
Material and methods: Sprague-Dawley rats were injected with Aggregatibacter actinomycetemcomitans LPS in periodontal tissue three times per week for 8 wk and part of the rats with LPS injection were also given simvastatin via gavage. After the treatments, the rat maxillae were scanned by microcomputed tomography and the images were analyzed to determine alveolar bone loss. To explore the underlying mechanisms, the effect of simvastatin on osteoclastogenesis and gingival expression of proinflammatory cytokines were also determined by tartrate-resistant acid phosphatase staining and real-time polymerase chain reaction assays, respectively.
Results: Results showed that LPS treatment markedly increased bone loss, but administration of simvastatin significantly alleviated the bone loss. Results also showed that LPS treatment stimulated osteoclastogenesis and the expression of inflammatory cytokines, but simvastatin significantly modulates the stimulatory effect of LPS on osteoclastogenesis and cytokine expression.
Conclusion: This study demonstrated that simvastatin treatment inhibits LPS-induced osteoclastogenesis and gingival inflammation and reduces alveolar bone loss, indicating that the intake of simvastatin may hinder the progression of periodontal disease.
Keywords: alveolar bone; inflammation; lipopolysaccharide; periodontal disease; simvastatin.
Published 2013. This article is a US Government work and is in the public domain in the USA.
Figures
Similar articles
-
Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.J Dent Res. 2014 Mar;93(3):294-9. doi: 10.1177/0022034513516980. Epub 2013 Dec 18. J Dent Res. 2014. PMID: 24352501 Free PMC article.
-
Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss.J Periodontal Res. 2013 Oct;48(5):541-8. doi: 10.1111/jre.12036. Epub 2012 Dec 30. J Periodontal Res. 2013. PMID: 23278592
-
MAP kinase phosphatase-1 protects against inflammatory bone loss.J Dent Res. 2009 Dec;88(12):1125-30. doi: 10.1177/0022034509349306. Epub 2009 Oct 28. J Dent Res. 2009. PMID: 19864641 Free PMC article.
-
Immune response: the key to bone resorption in periodontal disease.J Periodontol. 2005 Nov;76(11 Suppl):2033-41. doi: 10.1902/jop.2005.76.11-S.2033. J Periodontol. 2005. PMID: 16277573 Review.
-
Effective Modalities of Periodontitis Induction in Rat Model.J Vet Dent. 2024 Jan;41(1):49-57. doi: 10.1177/08987564231178459. Epub 2023 May 31. J Vet Dent. 2024. PMID: 37259505 Review.
Cited by
-
Evaluation of Crestal Bone Levels using Simvastatin as an Adjuvant Around Immediate Implants - A Clinico Radiographic Study.J Pharm Bioallied Sci. 2024 Feb;16(Suppl 1):S279-S282. doi: 10.4103/jpbs.jpbs_492_23. Epub 2024 Feb 29. J Pharm Bioallied Sci. 2024. PMID: 38595594 Free PMC article.
-
The role of autophagy in SIM mediated anti-inflammatory osteoclastogenesis through NLRP3 signaling pathway.Immun Inflamm Dis. 2024 Jan;12(1):e1145. doi: 10.1002/iid3.1145. Immun Inflamm Dis. 2024. PMID: 38270300 Free PMC article.
-
Role of various pharmacologic agents in alveolar bone regeneration: A review.Natl J Maxillofac Surg. 2023 May-Aug;14(2):190-197. doi: 10.4103/njms.njms_436_21. Epub 2023 Jul 13. Natl J Maxillofac Surg. 2023. PMID: 37661974 Free PMC article. Review.
-
GPR40 deficiency worsens metabolic syndrome-associated periodontitis in mice.J Periodontal Res. 2023 Jun;58(3):575-587. doi: 10.1111/jre.13107. Epub 2023 Feb 17. J Periodontal Res. 2023. PMID: 36807310 Free PMC article.
-
In Vitro and In Vivo Anti-Inflammatory Effects of TEES-10®, a Mixture of Ethanol Extracts of Ligularia stenocephala Matsum. & Koidz. and Secale cereale L. Sprout, on Gingivitis and Periodontitis.Dent J (Basel). 2022 Aug 2;10(8):143. doi: 10.3390/dj10080143. Dent J (Basel). 2022. PMID: 36005241 Free PMC article.
References
-
- Gotto AM, Jr, Moon JE. Management of cardiovascular risk: the importance of meeting lipid targets. The American journal of cardiology. 2012;110:3A–14A. - PubMed
-
- Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease. Vascular and endovascular surgery. 2010;44:241–251. - PubMed
-
- Paraskevas KI. Statin treatment for rheumatoid arthritis: a promising novel indication. Clinical rheumatology. 2008;27:281–287. - PubMed
-
- Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: a risk factor for coronary heart disease? Annals of periodontology / the American Academy of Periodontology. 1998;3:127–141. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical